Cargando…

Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease

Introduction: Vimentin has shown to be highly implicated in cancer initiation and progression. Vimentin is often a target of post-translational modifications (PTMs) which can be disease specific, thus targeting these specific modifications can be of high biomarker potential. In this study we set out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nissen, Neel Ingemann, Karsdal, Morten, Willumsen, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887574/ https://www.ncbi.nlm.nih.gov/pubmed/31827725 http://dx.doi.org/10.18632/oncotarget.27332

Ejemplares similares

In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
por: Drobinski, Patryk J., et al.
Publicado: (2022)

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
por: Nissen, Neel I., et al.
Publicado: (2019)

Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy
por: Jensen, Christina, et al.
Publicado: (2021)

Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma
por: Nissen, Neel I., et al.
Publicado: (2022)

Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
por: Willumsen, Nicholas, et al.
Publicado: (2019)

Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
por: Thorlacius‐Ussing, Jeppe, et al.
Publicado: (2023)

Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer
por: Crespo-Bravo, Marina, et al.
Publicado: (2023)

Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer
por: Willumsen, Nicholas, et al.
Publicado: (2017)

Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer
por: Willumsen, Nicholas, et al.
Publicado: (2014)

Hsp60 Post-translational Modifications: Functional and Pathological Consequences
por: Caruso Bavisotto, Celeste, et al.
Publicado: (2020)

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Nissen, Neel I., et al.
Publicado: (2021)

Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non–Small Cell Lung Cancer
por: Nielsen, Signe Holm, et al.
Publicado: (2018)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
por: Flies, Dallas B., et al.
Publicado: (2023)

Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2022)

Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer
por: Madsen, Emilie A., et al.
Publicado: (2022)

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma
por: Nissen, Neel I., et al.
Publicado: (2023)

Molecular Insight into the Regulation of Vimentin by Cysteine Modifications and Zinc Binding
por: Mónico, Andreia, et al.
Publicado: (2021)

Post translational modification of Parkin
por: Chakraborty, Joy, et al.
Publicado: (2017)

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
por: Seok, Jin Kyung, et al.
Publicado: (2021)

Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
por: Wang, Song, et al.
Publicado: (2021)

Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders
por: Jensen, Christina, et al.
Publicado: (2018)

Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
por: Jensen, Christina, et al.
Publicado: (2018)

Managing the complexity of communication: regulation of gap junctions by post-translational modification
por: Axelsen, Lene N., et al.
Publicado: (2013)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Proteomics of protein post-translational modifications implicated in neurodegeneration
por: Ren, Ru-Jing, et al.
Publicado: (2014)

Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification
por: Osaka, Natsuki, et al.
Publicado: (2021)

Post-Translational Modifications of TRP Channels
por: Voolstra, Olaf, et al.
Publicado: (2014)

Absolute quantitation of post-translational modifications
por: Chaube, Ruchi
Publicado: (2014)

Post-Translational Modifications of Exosomal Proteins
por: Moreno-Gonzalo, Olga, et al.
Publicado: (2014)

Orchestrating the proteome with post-translational modifications
por: Spoel, Steven H
Publicado: (2018)

Global Post-Translational Modification Discovery
por: Li, Qiyao, et al.
Publicado: (2016)

Post-Translational Modifications of Extracellular Proteasome
por: Tsimokha, Anna S., et al.
Publicado: (2020)

Dynamic post‐translational modifications in obesity
por: Yang, Hong, et al.
Publicado: (2019)

Post-translational protein modifications in schizophrenia
por: Mueller, Toni M., et al.
Publicado: (2020)

Post-translational Modifications of the Protein Termini
por: Chen, Li, et al.
Publicado: (2021)

Sirtuin Oxidative Post-translational Modifications
por: Kalous, Kelsey S., et al.
Publicado: (2021)

Editorial: Bacterial Post-translational Modifications
por: Carabetta, Valerie J., et al.
Publicado: (2022)

Post-translational modifications on the retinoblastoma protein
por: Zhou, Linbin, et al.
Publicado: (2022)

Post-translational modifications and their implications in cancer
por: Dutta, Hashnu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6n7cphod0r2bdqsu13cutsu51k